Perspective Therapeutics, Inc.CATXNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.97
↑ 96% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthElevated
Average
-44.42
Historical baseline
PeriodValueYoY Change
2025-1.97+24.1%
2024-2.59+45.4%
2023-4.75+48.7%
2022-9.24+61.0%
2021-23.72+82.7%
2020-137.44-19.5%
2019-114.98-102.9%
2018-56.67-53.0%
2017-37.05+33.6%
2016-55.80-